Tonometers Market Analysis

Tonometers Market Analysis

To get key market trends

  Download Free Sample

Based on technology, the market is segmented as applanation tonometer, rebound tonometer, indentation tonometer, and other technologies. The applanation tonometer segment accounted for majority revenue share in 2024 and is expected reach over USD 369 million by 2034.
 

• Applanation tonometers are widely recognized as the gold standard for measuring intraocular pressure (IOP), particularly in clinical settings. The demand for these devices is driven by their precision, reliability, and established use in diagnosing and monitoring glaucoma.
   
• Applanation tonometers can provide more reliable readings for patients with conditions like corneal edema when paired with pachymetry for adjustments. In addition, many applanation tonometers are integrated with slit lamp microscopes, allowing seamless use during routine eye exams.
   
• Furthermore, portable applanation tonometers are gaining traction, enabling use in non-traditional and remote settings.
   

Based on portability, the tonometers market is segmented as desktop and handheld. The desktop segment is expected to drive business growth and expand at a CAGR of 4.9%, reaching over USD 380 million by 2034.
 

• Desktop tonometers are ideal for settings with high patient turnover due to their accuracy and ability to perform multiple tests efficiently. Desktop models are robust and designed for extended use, making them a cost-effective choice for high-volume clinics over portable or handheld devices. Ophthalmologists and optometrists often prefer desktop models for their stability and reduced variability in results.
   
• Moreover, modern desktop tonometers now include automated IOP measurement and calibration features, improving ease of use and reducing operator dependency.
   
• Further, integration with electronic medical records (EMR) and other ophthalmic devices enhances workflow efficiency..
   

Based on end use, the tonometers market is classified into hospitals, ophthalmic clinics, ambulatory surgical centers, and other end users. The hospitals segment dominated the market with a revenue share of 42.4% in 2024.
 

• Hospitals handle a large and diverse patient base, including referrals for specialized care like glaucoma diagnosis and treatment, necessitating multiple tonometers to meet the demand. In addition, emergency cases, routine eye exams, and follow-ups for ocular conditions drive the continuous use of tonometers.
   
• Additionally, various hospitals are establishing or expanding dedicated ophthalmology departments, increasing the need for tonometers. Advanced tonometers are preferred in hospitals for managing patients with corneal irregularities, post-surgical eyes, or severe glaucoma.
   
• Moreover, hospitals adopting tele-ophthalmology programs will likely invest in tonometers with connectivity features for remote monitoring and consultation.
   

U.S. tonometers market accounted for USD 115.8 million in 2024 and is anticipated to grow at a CAGR of 3% between 2025 to 2034 period.
 

• The U.S. market is at the forefront of adopting automated, non-contact, and AI-enabled tonometers, enhancing diagnostic precision and patient comfort. Hospitals and clinics in the U.S. increasingly prefer tonometers that integrate with electronic medical records (EMRs) to streamline workflows.
   
• Favourable government and private initiatives for preventive care is a key factor propelling the product demand. Advocacy by organizations like the American Academy of Ophthalmology promotes routine eye exams, boosting demand for tonometers.
   
• Additionally, most diagnostic eye tests, including tonometry, are covered under Medicare and private insurance plans, making tonometry services accessible to a larger population. Reimbursement for early glaucoma screening encourages the adoption of tonometers in clinical practices.
   

France tonometers market is projected to grow remarkably in the coming years.
 

• Glaucoma is one of the leading causes of blindness in France, with the number of affected individuals expected to rise with the aging population. Regular intraocular pressure (IOP) measurement is crucial for early detection and management. As awareness around glaucoma and the importance of early detection grows, the demand for tonometers for routine screening will continue to rise.
   
• Moreover, the trend toward automation and AI will drive the demand for more advanced tonometers that can improve diagnosis accuracy and efficiency.
   

China holds a dominant position in the Asia Pacific tonometers market.
 

• With a considerable portion of the population over the age of 60, the risk of age-related ocular diseases, including glaucoma and cataracts, is rising in China. In addition, the growth in number of diabetes cases in the country is leading to an increase in diabetic retinopathy and other eye complications, which further drive the need for tonometry as part of regular eye exams.
   
• Further, AI-driven tonometers and the use of telemedicine for remote patient monitoring are increasingly becoming popular in China, especially in underserved areas, contributing to the demand for portable and easy-to-use tonometers for glaucoma and other eye disease monitoring.